Cluj-Napoca based startup Synaptiq receives a grant of 158.000 euros from the Innovation Norway grants for its Mediq software, a state-of-the-art technological solution based on data processing with the help of AI.
The application will help radiation oncologists to identify, delineate and diagnose in an extremely short time the tumours and organs-at-risk during radiotherapy treatment.
This technology concep is designed to reduce the time required to identify and delineate organs-at-risk and tumours from around four hours to a maximum of 5 minutes. Thus, the chances of survival for millions of patients worldwide will increase.
In 2020, more than 8 million people worldwide were diagnosed with cancer. From these, approximately 50% need radiotherapy treatment. Unfortunately, only 3 out of 4 patients get access to treatment.
This happens because of the lack of medical personnel and the complexity and long duration of the procedures. Even for those who have access to treatment, the time spent between diagnosis and treatment can be of 5 weeks.
The 158.000 euros received as grant by Synaptiq will be used to develop the technological solution and test a prototype in real clinical conditions, as well as continuously improve its performance.
After the validation and implementation of Mediq, doctors will be able to treat more patients, radiotherapy clinics will be able to allocate the saved financial resources to expand their facilities and services, and patients will receive the appropriate treatment much faster.
Synaptiq is a company founded more than two years ago in Cluj, by Dragoș Dușe, Mihai Căta, Roxana Săbău and Diana Andrițchi, and at the moment the team consists of 17 members.